Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5850_Библиотеки_им_академика_М_И_Перельмана
.pdf
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents
Foeniculum vulgare miller
Apiaceae
Humulus lupulus
L.Cannabaceae
Hyoscyamus niger
L.Solanaceae
Hypericum perforatum L Hypericin, hyperforin, quercetin, kaempferol,
Ilex aquifolium
L.Aquifoliaceae
Lactuca sativa L.Asteraceae Quercetin Antioxidant, antimicrobial, anxiolytic,
Laurus nobilis L.Lauraceae Pinene, terpineol, quercetin, kaempferol,
Lavandula angustifolia miller
Lamiaceae
Lavandula ofcinalis Chaix
Lamiaceae
Lavandula stoechas
L.Lamiaceae
Leucanthemum alpinum lam.
Asteraceae
Lolium multiorum lam.
Poaceae
Lolium perenne L.Poaceae Quercetin Antioxidant,
Lotus corniculatus
L.Fabaceae
Malva cretica Cav. Malvaceae Isoquercetin, quercetin, rutin, kaempferol,
Malva neglecta Wallr.
Malvaceae
Malva sylvestris
L.Malvaceae
Matricaria camomilla L.
(=Chamomilla recutita (L.)
Rauschert) Asteraceae
Matricaria discoidea
DC.Asteraceae
Melilotus ofcinalis pall.
Fabaceae
Rutin, quercetin, apigenin, and caffeic acid Antioxidant, antimicrobial, hypnotic,
Humulone, lupulon, naringenin, quercetin,
kaempferol, and taxifolin
Chlorogenic acid, rutin, quercetin, and
scopolamine
biapigenin, and rutin
Quercetin, rutin, kaempferol, and chlirogenin
acid
luteolin, and apigenin
Isoquercetin, quercetin, rutin, kaempferol,
and apigenin
Borneol, cineole, and linalool, Antioxidant, antimicrobial, anxiolytic,
Lupeol, amyrin, vanillin, rutin, luteolin, and
apigenin
Flavonoid Antioxidant
Chorogenic acid, Isoquercetin, quercetin,
rutin, kaempferol, apigenin,luteolin, and
ferulic acid
Quercetin, rutin, kaempferol, isorhamnetin,
luteolin, and biochanin
apigenin, and luteolin
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, luteolin, chrysin, coumarin, gallic
acid, and vanillin
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, and luteolin
Quercetin, rutin, kaempferol, apigenin, and
luteolin
Chorogenic acid, Isoquercetin, quercetin,
rutin, kaempferol, apigenin,luteolin,
isorhamnetin, and cosmosin
Coumarin, Isoquercetin, quercetin, rutin,
kaempferol, and apigenin
Active
biomolecule(s) Pharmacological effects
anxiolytic, antidepressant, and antiamnesic
Antioxidant, anxiolytic, insomnia,
antibacterial, antifungal, antiinammatory, and sedative-hypnotic
antidepressant
Antioxidant, antimicrobial, sedativehypnotic, and calming agent (anxiolytic)
antidepressant
Antioxidant, antimicrobial, anxiolytic,
anti-inammatory, sedative-hypnotic
antidepressant, and anti cancer
Antioxidant, antimicrobial, anxiolytic, and
sedative-hypnotic
sedative-hypnotic antidepressant, and
analgesic
Antioxidant, anxiolytic, anti-inammatory,
analgesic, sedative-hypnotic, and
antimicrobial
Antioxidant, anxiolytic, anti-inammatory,
and sedative-hypnotic
anti-inammatory, and sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
Anti oxidant, anti-inammatory, and
antimicrobial
Antibacterial, antioxidant, anxiolytic,
antidepressant, anti-inammatory,
sedative-hypnotic, anticancer,
Antioxidant, and anxiolytic
Antioxidant, anxiolytic, antimicrobial,
anticholinesterase, anti-inammatory, and
sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory,
antispasmodic, antidepressant, sedativehypnotic, hypolipidemic, anticonvulsant,
antiparasitic, an analgesic
Antioxidant, anxiolytic, anti-inammatory,
antispasmodic, antidepressant, sedativehypnotic, hypolipidemic, anticonvulsant,
antiparasitic, and analgesic
Antioxidant, antimicrobial, antibiolm,
anxiolytic, anti-inammatory, anticancer,
sedative-hypnotic, and analgesia
(continued)
259

260
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents
Melissa ofcinalis
L.Lamiaceae
Melittis melissophyllum
L.Lamiaceae
Mentha aquatica
L.Lamiaceae
Mentha piperita L.Lamiaceae Epicatechin, syringic acid, Isoquercetin,
Mentha spicata L.
(=M.Spicata L. subsp.
glabrata (Lej. and Courtois)
Lebeau) Lamiaceae
Mentha suaveolens Ehrh.
Subsp. suaveolens Lamiaceae
Mentha viridis L.Lamiaceae Quercetin, rutin, and kaempferol Antioxidant, anxiolytic, antimicrobial,
Myrtus communis
L.Myrtaceae
Nepeta cataria L.Lamiaceae Chlorogenic acid, quinic acid, Isoquercetin,
Ocimum basilicum
L.Lamiaceae
Olea europaea L.Oleaceae
[17]
Opuntia cus-indica (L.) mill.
Cactaceae
Origanum majorana
L.Lamiaceae
Origanum vulgare L. subsp.
viridulum (Martrin-Donos)
Nyman Lamiaceae
Paeonia mascula (L.) mill.
Paeoniaceae
Papaver rhoeas
L.Papaveraceae [19]
Papaver setigerum
DC.Papaveraceae [20]
Papaver somniferum
L.Papaveraceae
Pimpinella anisum
L.Apiaceae [21]
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, and rhamnocitrin
Myricetin,, quercetin, rutin, kaempferol,
apigenin, and luteolin
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, luteolin, and naringenin
quercetin, rutin, kaempferol, apigenin, and
luteolin
Quercetin, rutin, kaempferol, apigenin, and
luteolin
Isoquercetin, rutin, and apigenin Antioxidant, anxiolytic, antibacterial,
Linalool, myrecitin, Isoquercetin, quercetin,
rutin, kaempferol, and apigenin
quercetin, myricetin, nd apigenin,
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, catechin, naringin, and genistein
Luteolin, diosmetin quercetin, rutin,
kaempferol, apigenin, and oleuropein
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, and isorhamnetin[18]
Quercetin, rutin, apigenin, naringenin,
luteolin, and scutellarein
Quercetin, rutin, apigenin, naringenin,
luteolin, and scutellarein
Isoquercetin, quercetin, rutin, kaempferol,
and apigenin
Isoquercetin, quercetin, rutin, kaempferol,
and apigenin
Quercetin, ruti,, and apigenin Antioxidant, anxiolytic, anti-inammatory,
Isoquercetin, quercetin, rutin, kaempferol,
apigenin, and luteolin
Quercetin, rutin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Active
biomolecule(s) Pharmacological effects
Antioxidant, anxiolytic, antibacterial,
antiviral, anti-Alzheimer, antiinammatory, antidepressant, sedativehypnotic, cardioprotective, antidiabetic,
and analgesic
Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
Hepatoprotection, antioxidant, anxiolytic,
anti-inammatory, analgesic, sedative,
appetite stimulant, and anticonvulsant
Antispasmodic, antioxidant, anxiolytic,
anti-inammatory, analgesic, sedative, and
antidepressant
Antioxidant, antimicrobial, anxiolytic,
anti-inammatory, sedative-hypnotic,
antidepressant, and cytotoxic
anti-inammatory, analgesic,
sedative-hypnotic
anticancer, and anti-inammatory
Antioxidant, anxiolytic, antimicrobial,
anti-inammatory, anticancer,
antidepressant, and sedative-hypnotic,
Antioxidant, anxiolytic, antimicrobial,
antidepressant, anti-inammatory, and
sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory,
and sedative-hypnotic
Antioxidant, anxiolytic, neuroprotective,
anti-inammatory, analgesic, antifungal,
sedative-hypnotic, and anti-tumor
Antioxidant, anxiolytic, antibacterial,
anti-inammatory, analgesic, sedativehypnotic, antidepressant. Anticancer,
neuroprotective, and anti-viral
Antioxidant, anxiolytic, anti-inammatory,
and sedative-hypnotic
Antioxidant, anxiolytic, antimicrobial,
antidepressant, anti-inammatory,
antifungal, and sedative-hypnotic
Antioxidant, antimicrobial, anxiolytic,
analgesic, anti-inammatory, and
anticholinesterase
Antioxidant, anxiolytic, anti-inammatory,
and sedative
antifungal, and sedative
Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
analgesic, anti-inammatory,
antispasmodic, antidepressant, sedativehypnotic, antiviral, and anticonvulsant
S. O. Otimenyin

Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents
Polypodium vulgare
L.Polypodiaceae
Primula veris L.Primulaceae Quercetin, rutin, kaempferol, apigenin, Antioxidant, anxiolytic, and
Primula vulgaris Huds.
Primulaceae
Prunus persica (L.) Batsch
Rosaceae
Robinia pseudacacia
L.Fabaceae
Rosmarinus ofcinalis
L.Lamiaceae
Ruta chalepensis L.Rutaceae Quercetin, rutin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Salix alba L.Salicaceae Quercetin, rutin, and salicin Antioxidant, anxiolytic, anti-inammatory,
Salvia ofcinalis
L.Lamiaceae
Santolina insularis (Gennari
ex Fiori) Arrigoni Asteraceae
Senecio delphinifolius Vahl.
Asteraceae
Solanum nigrum
L.Solanaceae [22]
Sonchus oleraceus
L.Asteraceae
Stachys recta L.Lamiaceae Caffeoylquinic acid, rutin, and avonoids Antioxidant, anxiolytic, and
Tanacetum balsamita L.
(=Balsamita major Desf.)
Asteraceae
Thalictrum aquilegiifolium
L.Ranunculaceae
Thymbra capitata (L.) Cav.
Lamiaceae [23]
Valeriana ofcinalis
L.Valerianaceae [24]
Catechin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Quercetin, rutin, and kaempferol Antioxidant, anxiolytic, anti-inammatory,
Quercetin, rutin, kaempferol, apigenin, and
cinnamic acid
Myricetin, chorogenic acid, isoquercetin,
quercetin, rutin, kaempferol, apigenin,
naringenin, chrysoeriol, and isoliquiritigenin
Ferulic acid, rosmarinic acid, chorogenic
acid, Isoquercetin, quercetin, rutin,
kaempferol, apigenin, chlorogenic acid, and
rosmaric acid,
Quercetin, rutin, hesperidin, luteolin,
apigenin, chrysin, sagerinic acid,
pinocembrine, catechin, and cirsimaritin
, Luteolin, rhamnocitrin, andnepetin Antioxidant, anxiolytic, and
Quercetin Antioxidant, anxiolytic, anti-inammatory,
Quercetin, rutin, apigenin, apigenin, and
luteolin
Isoquercetin, nepetin, kaempferol, axillarin,
quercetin, rutin, apigenin, naringenin,
luteolin, scutellarein, isoramnetin,
hyperoside, and syringic acid [18]
Thalifoline Antioxidant, anxiolytic, and anti-fungal
Rosmarinic acid, quercetin, rutin,
kaempferol, and apigenin
Valerenic acid Insomnia
Active
biomolecule(s) Pharmacological effects
analgesic, anti-inammatory,
antidepressant, sedative-hypnotic,
antiviral, and anticonvulsant
anti-inammatory
and sedative-hypnotic
Antioxidant, anxiolytic, antimicrobial,
anti-inammatory, antispasmodic,
antidepressant, sedative-hypnotic,
anticholinesterase, anti-obesity, and
hepatoprotective
Antioxidant, anxiolytic, antimicrobial,
anti-inammatory, antifungal,
antidepressant, inhibits interleukin-1B, and
antiviral
Antioxidant, anxiolytic, antimicrobial,
analgesia, anti-inammatory,
neuroprotective, sedative-hypnotic,
antitumor, and anticonvulsant
antipyretic anti-inammatory,
antidepressant, sedative-hypnotic, and
anticonvulsant
and analgesia
Antioxidant, anxiolytic, and antimicrobial
anti-inammatory
Antioxidant, anxiolytic, anti-inammatory,
cytotoxic
and antidiabetic
Antioxidant, antimicrobial, anxiolytic,
gastroprotective, anti-inammatory, and
anti-cancer
anti-inammatory
Antioxidant, anxiolytic, anti-inammatory,
and ant-spasmodic
Antioxidant, anxiolytic, and
anti-inammatory
Restlessness
Insomnia
Restlessness
261

262
https://t.me/medicina_free
Table 3 Mechanism of selected avonoids found in anxiolytic and sedative/hypnotic plants
Name Similar brain chemical Uses/effects Mechanism(s)
7, 8-dihydroxyavone [25] Anti-depressant and
Parkinson’s disease
Amentoavon [25] Cnestis ferruginea Vahl
ex DC
Apigenin [27] Antioxidant, anti-
Baicalein
(5, 6, 7-trihydroxyavone)
Chrysin Found in honey Antineoplastic, antioxidant,
Luteolin [30]
(3′, 4′ 5, 7, tetrahydroxyavone)
Orientin Highly abundant in
Nobiletin
(5,6,7,8,3′,4′-hexamethoxyavone)
Icariin Anti-depressant [31] Icarin inhibits inducible nitric oxide
Vitexin
(is an apigenin avone glucoside)
Fisetin
(7, 3′, 4′-avon-3-ol)
Scutellaria baicalensis
Georgi
Cirsium japonicum
Var. Maackii
herbs, fruits, and millet
Passiora incarnates L. Antitumor, anti-
Fruits (especially
strawberries) and
vegetables are rich in
setin
Neuroprotective action,
antioxidant, and antiinammatory anxiolytic and
antidepressant
inammatory, anti
depressant, and antitumor
activities [28, 29]
Antioxidant antidepressant Increase ERK phosphorylation and elevate
anti-inammatory,
antidepressant, and
hypolipidemic
Anticancer, antioxidant,
anxiolytic, memory-boosting
properties, and antidepressant
effects
Antioxidant activity and
antidepressant
Neuroprotection
Anti-depressant
inammatory, analgesic, and
antioxidant
Anxiolytic and antidepressant activities
Anti-inammatory,
antioxidant, and
neuroprotective
antidepressant
It acts on activated TrkB (tropomyosin
receptor kinase B) receptors and nitric
oxide signaling pathway
It mimics brain-derived neurotrophic factor
(BDNF) and also elevates BDNF
expression and levels in the hippocampus
[26]
Acts via interactions with serotonin
(5-HT2), ionotropic GABA (gammaaminobutyric acid), and adrenergic
receptors (α1- and α2-), [26]
Apigenin inhibits NLRP3 inammasome
expression, upregulates PPAR (peroxisome
proliferator-activated receptor) expression,
and inhibits IL-1 production.
Up-regulates the level of BDNF in the
hippocampal region of the brain and
inhibits mono-amino oxidase enzyme
hippocampal BDNF expression
Increase levels of BDNF and dopamine in
the hippocampus
Inhibit cyclooxygenase
Chrysin up-regulates BDNF expression and
elevates BDNF levels in the hippocampus
and prefrontal cortex
It also modulates 5-hydroxy-tryptamine
metabolism, caspase activities, proinammatory cytokines synthesis, and
kyanize
Actions are mediated via potentiation of
GABA-A
Decrease stress-related protein of the
endoplasmic reticulum,
Inhibit the MAO enzyme resulting in an
increase in CNS neurotransmitter levels
Increases amine neurotransmitters in the
brain by inhibiting MAO and increases
synaptic proteins and BDNF expression in
the prefrontal cortex and hippocampus
Noboletin interaction with dopaminergic
(D1 and D2), noradrenergic (α1), receptors,
and serotonergic (5-HT1A and 5-HT2)
receptors
synthase enzyme activity. It also elevates
hippocampal BDNF levels [32, 33]
Vitexin inhibits urease, platelet aggregation,
α-glucosidase, and adipogenesis
Mediated via interaction with
serotonergic(5-HT1A), dopaminergic (D1,
D2, and D3), and noradrenergic(α2)
receptors. It also increases the synaptic
concentration of this neurotransmitter
Its action is mediated via activation of the
TrkB signaling pathway and leads to an
increase in phosphorylation of TrkB level
without disturbing total TrkB
S. O. Otimenyin

Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 3
Name Similar brain chemical Uses/effects Mechanism(s)
Isoquercitrin St. John’s wort Anti-depressant
Kaempferitrin Justicia spicigera
Kaempferol Fruits and vegetables Anti-depressant [35]
Myricetin In fruits, red wine,
Myricitrin [36] Antidepressant, antioxidant,
Quercetin
[38]
Rutin Vegetables, citrus
Flavanone Anti-inammatory and
Hesperidine hesperidin Antidepressant
Naringin
(4′-hydroxyavanones)
Naringenin Citrus fruits peel Anti-inammatory,
Silibinin Cardioprotective
Flavan-3-ols (−)-epicatechin and
(+)-catechin
Astilbin Hypericum perforatum Anti-inammatory
Dihydromyricetin Cercidiphyllum
Schltdl
berries, vegetables,
nuts, and tea
Broccoli, wine, apple,
onion, and plants (e.g.,
Green tea), [39]
fruits, and plants (such
as gs, green, and
black tea
Cocoa
Uncaria rhynchophylla
(Miq
japonicum
Salix sachalinensis
Antioxidant [34]
Anti-depressant Regulates the HPA axis and modulates the
Anti-apoptotic
Anti-inammatory, antidepressant, antioxidant, and
neuroprotective
anti-brotic, and antiinammatory [37]
Anti-depressant [40]
Antiinfamatory
Anti-inammatory,
neuroprotective, anti-tumor,
and antioxidant
antioxidant
Antioxidant
Antioxidant, antidepressant,
Anticarcinogenic, and blood
lipid-lowering
antioxidant, neuroprotective,
cognition enhancer,
anti-bacterial, and
wound-healing
Anti-inammatory
Anticancer
Anti-depressant [41]
Anxiety and depression Inhibiting MAO-B enzyme activity
antioxidant, and
antidepressant [42]
Anti-depressant Increase in BDNF expression and inhibit
Isoquercitin elicits these actions via the
modulation of hypothalamus/pituitary axis
(HPA) functions. It prevents hypersecretion
of adrenocorticotropic hormone and
cortisol
serotonergic system (mainly, presynaptic
5-HT1A receptors)
Elevates plasma β
epinephrine, dopamine, and serotonin
(reduces serotonin metabolism)
concentration
Increases the activity of enzyhippocampus
glutathione peroxidase and BDNF level
Inhibition of MAO enzyme
Elevates CNS monoamine level and
increases hippocampal BDNF and
expression
Increase in hippocampal BDNF
concentrations, activate dopaminergic
systems, and enhance 5-HT1A receptors. It
also inhibits monoamine oxidases and
suppresses neuro-endocrine signaling
Inhibits cytochrome P450 enzymes
(CYP1A2)
MAO inhibitor
Suppress neuro-endocrine signaling
Alters endocrine, immunological, and
monoamines (5-HT, DA, and NE). Alters
MDA formation, IL-6, TNF-α, and BDNF
levels
Up regulates neurotransmitter release and
BDNF signaling pathway [43]
neuro-inammation [44]
263
-endorphin, nor-

264
https://t.me/medicina_free
S. O. Otimenyin
5 Anxiety
Anxiety is one of the most common mental illnesses plaguing one-eighth of the total population and has become of
great economic burden in most countries. It is a psychiatric
problem that is not easily recognized and attended to. Anxiety
is a persistent feeling of apprehension, dread, and impending
disaster, or uneasiness and/or tension. It is a precise class of
psychopathology that presents with future-oriented apprehension and increased threat value associated with mental,
physical, and social stimuli. Anxious people may commit
crimes to cover up the source or cause of anxiety.
Over the years, anxiety has received great attention. This
has led to the discovery of a number of drugs thought to be
of help in managing anxiety. As a central nervous system
(CNS) disorder, it has become a very important area of
research in psychopharmacology. Stress often precedes anxiety, hence the word “‘stress-induced anxiety.” Anxiety is a
common psychiatric problem that has been aggravated by
the style of this modern world and lifestyles. Pressure from
work, pairs groups, families, and self-ambition are some of
the numerous predisposal to anxiety. As humans, it is in our
traits to be a little stressed and anxious, this is healthy for the
progress and development of the human race and for achieving great ts. Stress and anxiety could motivate an individual
and spur such to be more productive. Too much of everything
appears to be bad in all areas, so also in stress and anxiety. It
could cripple an individual if such an individual is stressed
beyond boundaries and over anxious. It could result in poor
health as well as specic psychological or physical illnesses
like depression and insomnia. The inability to control persistent stress can lead to anxiety and unhealthy behaviors.
Anxiety is a common emotional phenomenon in humans,
and it is an unpleasant emotional state that is associated with
concern or fear about some dened or undened future
threat, uneasiness, and discomfort.
Anxiety, as presented in normal individuals, is characterized by
2. Symptoms of anxiety include (a) physiological, (b) cognitive, and (c) behavioral symptoms.
(a) Cognitive distortions, lack of attention, interpreta-
tion, and memory for information processing [10].
(b) Physiological aspects of anxiety include autonomic
or somatic sensations. It also includes avoidance
related to nightmares, sleep, insomnia, and fear of
sleeping alone. Increased heart rate, heart palpitations, shortness of breath, chest pain, nausea, and difculty in swallowing.
(c) Behavioral aspects of anxiety disorders include:
avoidance of self-acclaimed fearful events, avoidance of specic stimuli (individual, things) that are
presumed to make the subject fearful (e.g., bridges),
or avoidance of situations (e.g., public speaking) that
make the sufferer uncomfortable. These results in the
inability to carry out or maintain daily routines in
academic, family, and/or social functions.
Anxiety disorders are disturbing psychiatric disorders
affecting all the population. About 30.5% of women and
19.5% of men are affected and nearly 25% of the adult popu-
lation at some point in their life is affected. Young adults are
more plagued with anxiety, attention must be given to this
population if the nation is to have a future. Anxiety can
aggravate many physical and mental ailments and also
impede recovery from any other problems.
Identifying the cause of the anxiety (anxiogenic stimulus)
may be the way to go in the management of anxiety. A subject may experience anxiety at a particular moment when the
causative factor is present. The levels of anxiety in this case
depend on the level of the anxiogenic stimulus. This can be
referred to as “State anxiety”, and it varies from time to time
depending on the presence of the stimulus. Some subjects
experience an enduring anxiety (“Trait anxiety”) that cannot
be tied to a particular cause. This type of anxiety does not
vary from moment to moment; it endures in the subject and
may become a feature of the subject.
1. heart palpitations
2. nausea and fatigue
3. shortness of breath and respiratory insufciency
4. fear of the unknown
5. over reaction to minor issues
6. and inability to make progress
5.1 Symptoms ofAnxiety
1. Trembling, sweating, feelings of choking, abdominal distress, nausea, dizziness, pins and needles, feelings of
impending doom, or losing control over minor issues.
5.2 Management ofAnxiety
There are orthodox medicines known to improve the lifestyle of subjects with anxiety, but these drugs have side
effects that interfere negatively with the lifestyle of the
subject. Most subjects resort to psychotherapy and the use
of herbal medicinal agents. Research has isolated herbal
preparations that are helpful in the management of anxiety.
Herbal medicines seem to work well for those subjects
with mild to moderate symptoms of anxiety and sleep disorders. The use of natural or herbal remedies for the management of disease conditions by man has increasingly

Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
265
gained attention in recent times, partly because of the high
cost of drugs and because of the side effects and nonacceptability. Some believe that evil spirits are responsible
for CNS disease, and they use herbs and incantations to
ward away the spirits and regain normalcy. This method
works, not because spirits are driven away, but as a form of
psychotherapy and distractor from the cause of anxiety or
any related CNS disorders. Different types and forms of
herbal medications are used for self- treatment of various
stress-related afictions. Research studies have shown that
some of these plants have one or more CNS effects.
Research studies into many that have not been researched
have been advocated.
5.3 Types ofAnxiety Disorders
Anxiety disorders encompass the following clinical
conditions
1. Panic disorder
2. Social anxiety disorder and phobias
3. Generalized anxiety disorder
4. Post-traumatic stress disorder
5. Obsessive–compulsive disorder.
5.3.1 Generalized Anxiety Disorders
This disorder involves a broad presentation of anxiety.
Generalized anxiety disorder presents with long-lasting
anxiety that may span up to or over 6months. Such anxiety
may have more than one causative situation and may not be
focused on one causative object or situation. Subjects with
this type of anxiety experience persistent fear (non-specic–
cannot be traced to a real fear stimulant) and worry (when
there is no cause to worry) and become overly disturbed with
everyday stuff like health, money, work, family, and experience these symptoms even when there are no clear signs of
trouble in this aspect of their life.
times difculty in breathing, lasting for a few minutes or longer. The patient believes that he is seriously sick or about to
die. This feeling can leave the person shaken or depressed
immediately after the experience and for a period of time.
Panic disorder results in marked impairment in function if it
continues for a sustained period of time.
5.3.4 Social Anxiety Disorder
Social anxiety disorder is a marked and persistent fear of
performance or social situations. The person feels he is not
measuring up with social requirements and obligations.
5.3.5 Phobias
A phobia is an exaggerated or unrealistic fear of a specic
stimulus: darkness, heights, enclosed places, cooking re, or
other situations. Phobic individuals sometimes experience
full panic attacks after exposure to unrealistic stimuli. Phobia
seems the most common form of anxiety disorder. Panic disorders are not common and are fairly rare occurrencesin the
general population.
5.4 Physiology ofAnxiety
The brain is a complex organ and is the center of the human
nervous system. It controls the “mind” and the physical
activities. Its importance explains why it is well secured and
protected from the outside world and most chemical agents
that may interfere with its functioning. The Locus ceruleus
and the amygdala in the brain trigger a response to danger
and the acquisition and expression of fear conditioning,
respectively. Over activity/hyperactivity in the locus ceruleus transmits signals to the amygdala, which is sensed as
danger. The resultant instinct is the instruction to run from
danger and activation of the heart to beat faster, the lungs to
take in more air (breathing to become rapid), and in turn,
activates all the biological components of ght/ight
response.
5.3.2 Obsessive–Compulsive Disorder
This type of anxiety disorder presents with obsessions;
recurrent thoughts of danger or threat that do not exist or
may not be about real-life threat or problem, which the
patient fails to suppress or ignore. Compulsions present as
repetitive behaviors that the patient feels pushed to execute
in response to an obsession. The compulsive behaviors are
thought to be an attempt to reduce the distress from the
obsessions. The behaviors may not be benecial to the person or the community.
5.3.3 Panic Disorder
Subjects with this disorder present with apprehension and
brief attacks of intense terror, which is often characterized by
shaking, confusion, trembling, dizziness, nausea, and some-
5.4.1 Symptoms ofAnxiety
• Increase in breathing rate and increase in heartbeat
• Trembling/twitching
• Muscle contraction
• Headaches
• Sweating
• Difculty in swallowing/dry mouth
• Abdominal pain
Other symptoms include:
• Dizziness/blurred vision
• Sexual problems
• Diarrhoea or urinary urgency
• Irritability/loss of temper
• Fearful dreams, nightmares, or/and sleeping difculties
• Decreased concentration

266
https://t.me/medicina_free
S. O. Otimenyin
The symptoms of anxiety are normal to every individual,
and it is intended for the safety of the person. It is a series of
events that alert the person to danger and proffer a solution to
be safe. In most cases, it signals the person to run from the
point of danger. A problem arises if these responses proceed
beyond normal.
5.5 Mechanism ofAnxiety
The brain performs its functions by varying the concentrations of neurotransmitters at various synapses, varying the
population of receptors expressed on the recipient cells, and
altering the state of the neurons in it. Anxiety is a recognized
state of the brain, which is known to be one of the most
important emotional processes with rm neurobiological
roots. The mechanism of anxiety and its neurochemistry is
not well understood. This has made it a major area of
research, and the outcome of this research has led to new
approaches to the management of anxiety. Anxiety is thought
to occur as a result of an imbalance in the neurochemistry of
the brain. Some neurochemicals are on the high side while
others are very low. A number of neurotransmitters are
thought to be involved in anxiety. The levels of these neurotransmitters determine the type of anxiety, and the ease to
resolve and manage. Neurochemicals that may be involved
are acetylcholine, adrenaline, dopamine, endorphins, serotonin, gamma amino butyric acid, glutamate, etc.
The brain is complex and difcult to isolate parts for indepth research that could give a clue to understanding its
action. Most research has been centered on the drugs that
have an effect on the brain: either worsening a disease condition or alleviating the disease condition. In the case of anxiety, most information has come from studying the action of
anxiety-reducing or anxiolytic drugs on the brain: their
effects on the levels of the neurochemicals at known regions
of the brain. The results obtained when compared with a
non-anxious brain reveal that anxiety is caused by the dysfunction of one or more neurotransmitters and their receptors. The gamma amino butyric acid (GABA) mechanisms,
the serotonergic system, noradrenergic mechanisms, and
neuropeptides have been implicated in anxiety. Adenosine
and cholecystokinin have also been implicated in anxiety.
GABA is an inhibitory neurotransmitter in the brain, and
it regulates neuronal excitability, a mechanism by which it
eases stress and calms the brain. The GABA receptors (especially GABAA receptors) regulate the neuronal excitability
that is responsible for rapid mood changes (e.g., panic, anxiety, and stress response) via fast inhibitory synaptic transmissions. Drugs that sedate the brain (e.g., benzodiazepines,
barbiturates, neurosteroids, and ethanol) are thought to act
via GABAA receptors. These drugs elevate GABA levels or
enhance GABA-mediated transmission and are known to be
targets of sedating drugs. Action such as alteration of the
inux of chloride ions within this receptor complex is associated with the development of anxiety. All commonly used
anti-anxiety agents (barbiturates, benzodiazepines, and ethanol) selectively enhance only GABA-mediated transmission,
exerting anti-anxiety, relaxing, and anti-convulsant effects.
Serotonin/serotonin receptors have long been implicated
in anxiety in various animal models. Reduced levels of serotonin and its action on the serotonin 1A (5HT1A) receptor
can produce anxiolytic effects. Serotonin 1A receptor subtype (5-HT1A) is an autoreceptor located presynaptically on
serotonin neurons. When stimulated, this receptor inhibits
the synthesis and release of serotonin, thereby reducing its
post-synaptic activity. This action mimics the action of a
serotonin antagonist (which causes sedation) in the brain.
Buspirone, a 5 HT 1A agonist, exhibits anxiolytic effects in
animals and is useful in the treatment of generalized anxiety
disorder but not in panic disorder. The 5-HT2A, 5-HT2C,
and 5-HT3 receptors are also thought to be involved in the
mechanism of anxiety.
The neurotransmitter released from adrenergic nerves in
the brain, noradrenaline, is helpful in situations of emergencies or ght/ight response. Noradrenaline is elevated in
these emergencies, but when its levels are elevated when
there is no danger or emergencies, anxiety, fear, and irritability states are produced.
6 Neurotransmitters inAnxiety
6.1 Dierent Neurotransmitters Involved
inAnxiety
6.1.1 Gamma-Amino Butyric Acid
1. The main inhibitory neurotransmitter in the brain is the
Gamma-amino butyric acid (GABA). Anxiety regulation
is centered on GABA.GABA is the target of most drug
therapies.
2. GABA controls excitability states in areas of the brain.
The brain state at a particular point in time is determined
by the equilibrium between inhibitory GABAergic activity and excitatory inputs (mostly glutamatergic).
3. Sedation often implies that the balance is swinging
toward GABA. The subject may also experience ataxia
and/or amnesia.
4. Arousal, anxiety, restlessness, insomnia, and exaggerated
reactivity result from the mildest attenuation of the
GABAergic system.
6.1.2 Glutamate
1. L-glutamate in the mammalian brain and spinal cord has
been known to be the main excitatory transmitter in the
brain since the 1950s.

Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
267
2. Glutamate is the main excitatory neurotransmitter in the
central nervous system (CNS).
3. Glutamate is distributed all around the brain (ubiquitous).
It plays important roles in brain functions, including
acute neurodegeneration (e.g., cerebral ischemia and
traumatic brain injury), neurodevelopment (e.g., differentiation, migration, and survival), chronic neurodegeneration (e.g., Huntington’s disease and Alzheimer’s disease),
learning (e.g., long-term potentiation and depression),
and, more recently, the stress response and anxiety
disorders.
4. Glutamate through its wide range of presynaptic receptors controls the synaptic release of neurotransmitters.
These controls are effected via the Group II and Group III
glutamate metabotropic receptors, cholinergic (nicotinic
and muscarinic) receptors, adenosine (A1), kappa opioid,
γ-amino butyric acid (GABA B), cholecystokinin, and
neuropeptide Y (Y2) receptors.
5. The glutamatergic system plays a major role in the pathogenesis of fear conditioning and anxiety.
6. Glutamatergic neurotransmission in the limbic system
plays a pivotal role in the pathogenesis of anxiety
disorders.
7. Neuronal damage and/or death are often caused by severe
stress exposure, which directly leads to glutamate
excitotoxicity.
8. A decrease in the CNS levels of endogenously released
glutamate induces anxiolysis. A decrease in brain concentration of endogenously released glutamate results
in the activation of fewer NMDA receptors, but to a less
extent the CNS excitation would remain at a stable
stage. Such an effect can be achieved by switching on
the regulatory machinery of presynaptic glutamate
release.
Monosodium glutamate (MSG) [C5H8NO4NaH2O] is
one of the avor enhancers. It is sometimes added to food
during cooking as an ingredient in various food products.
Monosodium glutamate is a sodium salt of naturally occurring (non-essential) L-form of glutamic acid. Glutamate is
linked to metabolic syndrome and obesity that is not dependent on calories ingested and physical activity. It is reported
to be neurotoxic, which may be due to over excitation of the
neurons.
6.1.3 Serotonin (5HT)
1. The persistence of anxiety disorders and their develop-
ment is controlled by 5-HT and GABA
2. A decrease in central nervous system 5-HT concentration
increases anxiety symptoms, while an increase decreases
anxiety symptoms
3. Serotonergic neurons play a major role in sleep, mood,
appetite, cognitive, and energy symptoms in anxiety
4. 5HT modulates the effect on the locus coeruleus and its
projections to the amygdale (areas that have a prominent
role in anxiety)
5. Stress and fear activate serotonergic pathways in the brain
6. Venlafaxine (an SNRI) inhibits neuronal uptake of 5-HT
and resolves the patient’s anxiety
6.2 Management ofAnxiety
The nature or type of the anxiety disorder and the subject’s
personality or characteristics determine the drugs that would
be used and the method of management of anxiety.
Psychotherapy, the use of orthodox drugs, and the use of
alternative medications are the options for the management
of anxiety.
Drugs: The rst line of drugs for the management of anxiety (especially generalized social phobia) are the selective
serotonin reuptake inhibitors (SSRIs). This class of drugs
elevates the serotonin levels in the brain. Examples include
uoxetine, sertraline, paroxetine, citalopram, etc.
Benzodiazepines are also used in the management of anxiety. This class of drugs enhances the effects of GABA in the
brain. Examples of benzodiazepines include diazepam,
chlordiazepoxide, etc. Monoamine oxidase inhibitors
(MAOIs) (phenelzine and moclobemide) prevent the breakdown of serotonin and noradrenalin. Beta-blockers like propranolol and atenolol, which reduce the ability to produce
adrenaline, are other classes of drugs that are useful in the
management of anxiety. The common limitations of anxiety
medications or drug therapy include co-morbid psychiatric
disorders and an increase in dose leading to unbearable sideeffects, such as allergic reactions, nausea, fatigue, drowsiness, coordination problems, mental confusion, and addiction
liability among others.
Psychotherapy: Activities that can reduce the concentration or activity of stress neurotransmitters or neurochemicals
are benecial to subjects with anxiety. Counseling, removal
of causative factors of anxiety, provision of needs, etc. may
alleviate anxiety states. Cognitive-behavioral therapy and
exposure therapy are effective in the management of anxiety
disorders. Through psychotherapy, the pattern of thinking
(Cognitive therapy) of the subject can be changed; this often
diverts the subject’s attention from the causative thoughts.
Changes in beliefs that are associated with, and trigger, anxiety could also be helpful to the subject. Behavior therapy
works when the subject is exposed the reality. Subjects are
trained to confront their fears to desensitize them from the
anticipated dangers/fears that are triggering anxiety.
Alternative Treatments: Some exercises have a positive
impact on subjects with anxiety. Exercises that remould the
mind and the thinking and belief of the subjects with anxiety
have been found to be benecial. Meditation, a form of mind

268
https://t.me/medicina_free
S. O. Otimenyin
exercise, is benecial to subjects with phobias and panic disorders, and it diverts their attention from the causative factor
of anxiety (phobia and fear).
Hydrotherapy: Promotes general relaxation of the nervous system. Exercise engages the subjects and diverts their
focus of thought. Generally, exercise is a natural stress buster
and anxiety reliever, and it strengthens the nerves and makes
them more resilient. Relaxation techniques (Yoga) could be
employed in the management of anxiety. These techniques
include progressive muscle relaxation and controlled breathing which when practised regularly relieves anxiety. Sensors
that measure physiological functions like heart rate, breathing, and muscle tension give feedback (biofeedback) that
helps recognize the body’s anxiety response. The information generated helps stimulate subjects to use relaxation
techniques. Sleep is an important endeavor of man and animals. It helps to relax the brain and protect it from the outside world. It refreshes and prepares animals for a new day
and events. Most anxious subjects often present with insomnia caused largely by their fears. Efforts are made through
cognitive-behavioral therapy to make subjects sleep.
Induction of sleep (Hypnotherapy) involves the application
of different therapeutic approaches to help the subject sleep.
Sleep often causes a state of deep relaxation (mind and muscle relaxation). Medicinal plants with hypnotic activity are
benecial in the induction of sleep in anxious subjects.
Chinese traditional medicine utilizes acupuncture to help
alleviate anxiety. This works under the strong belief that it
relaxes the mind and muscles and subsequently may induce
sleep.
7 Herbal Anxiolytes
Plants are the major natural resource that are used in alternative medicine. They are used solely or in combination with
other natural substances. Plant parts consist of seeds, owers, leaves, stems, and roots. All these parts contain varying
concentrations of a particular biomolecule found in that
plant. Some plants concentrate some bioactive agent preferentially in their leaves, stem, or root. Medicinal plants used
for the management of anxiety utilize any of the parts for the
treatment of anxiety.
7.1 Isomnia
Insomnia is a state of lack of sleep or inadequate sleep. It can
occur if a subject is over stressed. Insomnia is the most common sleep disorder, about one-third of the world population
suffers from a long-term derangement of sleep and wakefulness [45]. Medicinal plants that have been reported to have
hypnotic effects are listed in Table3.
Abnormality in various pathways in the brain has been
credited for sleep disorders. Cortisol, GABA receptor and
cytokines levels, circadian rhythm (melatonin secretion and
adenosine receptors), and excitatory amino acid (glutamate
and aspartate) are thought to have malfunctioned/altered to
cause insomnia [46].
References
1. German-Ponciano LJ, Rosas-Sánchez GU, RivadeneyraDomínguez E, Rodríguez-Landa JF. Advances in the preclinical study of some avonoids as potential antidepressant agents.
Scientica. 2018;2963565:1–14.
2. American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 5a ed (DSM-5). Arlington: American
Psychiatric Publishing; 2013.
3. American Psychiatric Association. Diagnostic and statistical
manual of mental disorders. 4th ed. Washington, DC: American
Psychiatric Association; 1994.
4. Taylor DJ, Lichstein KL, Durrence HH.Insomnia as a health risk
factor. Behav Sleep Med. 2003;1(4):227–47.
5. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G,
Murray CJ, Vos T, Whiteford HA.Burden of depressive disorders
by country, sex, age, and year: ndings from the global burden of
disease study. PLoS Med. 2013;10(11):e1001547.
6. Institute of Health Metrics and Evaluation. Global Health Data
Exchange (GHDx). Htts://vizhubhealthdataorg/gbd- results/.
Accessed 4 march 2023.
7. Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J,
Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G,
Gureje O, Haro JM, He Y, Hu C, Karam EG, Kawakami N, Lee S,
Lund C, Kovess-Masfety V, Levinson D, Navarro-Mateu F, Pennell
BE, Sampson NA, Scott KM, Tachimori H, ten Have M, Viana
MC, Williams DR, Wojtyniak BJ, Zarkov Z, Kessler RC, Chatterji
S, Thornicroft G.Socio-economic variations in the mental health
treatment gap for people with anxiety, mood, and substance use
disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018;48(9):1560–71.
8. Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M,
Stubbs B, Schuch FB, Carvalho AF, Jacka F, etal. The effects of
dietary improvement on symptoms of depression and anxiety: a
meta-analysis of randomized controlled trials. Psychosom Med.
2019;81:265–80.
9. Dwyer AV, Whitten DL, Hawrelak JA.Herbal medicines, other than
St. John`s wort, in the treatment of depression. Sci Rev Altern Med.
2011;16(1):281–4.
10. Tegegne MT, Mossie TB, Awoke AA, Assaye AM, Gebrie BT,
Eshetu DA.Depression and anxiety disorder among epileptic people at Amanuel specialized mental hospital, Addis Ababa, Ethiopia.
BMC Psychiatry. 2015;15(1):210.
11. Kessler D, Bennewith O, Lewis G, Sharp D. Detection of
depression and anxiety in primary care: follow up study. BMJ.
2002;325(7371):1016–7.
12. Unützer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, Wells
KB.Mental disorders and the use of alternative medicine: results
from a national survey. Am J Psychiatry. 2000;157(11):1851–7.
13. Knaudt PR, Connor KM, Weisler RH, Churchill LE, Davidson
JR.Alternative therapy use by psychiatric outpatients. J Nerv Ment
Dis. 1999;187(11):692–5.
14. Khan RA, Riaz A.Behavioral effects of Citrus Limon in rats. Metab
Brain Dis. 2015;30(2):589–96. https://doi.org/10.1007/s11011-
014- 9616- 2. Epub 2014 Sep 17.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
